Psilocybin-Assisted Therapy

Psyence Biomedical Will Undertake Psilocybin Clinical Trials For Palliative Care In Australia
Psilocybin-Assisted Therapy Achieves Positive Clinical Trial Results For Treating Generalized Anxiety
Canadians View Psilocybin Therapy As 'Reasonable Medical Choice' For End-Of-Life Distress, New Study Reveals
Psilocybin-Assisted Therapy Achieves Positive Clinical Trial Results For Treating Generalized Anxiety
Canadians View Psilocybin Therapy As 'Reasonable Medical Choice' For End-Of-Life Distress, New Study Reveals
Psilocybin Therapy Trials: Gambling Addiction Study, Opioid Pain & Alcohol Addiction Trials
Psilocybin Therapy: Potential For Treating Alcoholism Examined In APA Publication

Psilocybin-Assisted Therapy Recent News

Canadian Psychedelics Company And Nonprofit Team Up To Accelerate Access And Product Launch
Health-Canada licensed psychedelics biotech Lucy Scientific Discovery (NASDAQ: LSDI) and not-for-profit psilocybin advocate organization TheraPs
Psychedelics And The Spectrum: Groundbreaking Study Details How One Firm Approaches Autism
The partnership between contract research organization KGK Sciences Inc. and Nova Mentis Life Science Corp. (OTC: NMLSF) has started <
EXCLUSIVE: Canada Takes Center Stage With Large Scale Psilocybin Macrodose Trial
The Canadian biopharma company advancing at-home psilocybin microdose studies and supporting Veteran patients, Apex Labs Ltd., has received Health Canada’s approval for a comprehensive, “statistically powered” macro-and-multi dose advanced psilocybin trial on 160 patients. 
Psilocybin Therapy Continues To Show Positive Outcomes For Cancer And Major Depression Disorder
Results from an advanced clinical trial assessing psilocybin-assisted therapy for patients with cancer and Major Depressive Disorder (MDD) conducted by oncology center Sunstone Therapies were published in the acclaimed JAMA Oncology.
Clinical Site In Alberta Begins Study Of Psychedelic-Assisted Treatment For Alcohol Use Disorder
Calgary-based SABI Mind is the first clinical site to receive approval from the Health Research Ethics Board of Alberta (HREBA) to launch a trial assessing psilocybin-assisted psychotherapy for the treatment of Alcohol Use Disorder (AUD).
Australia's Psychedelics Therapy Provides Hope For Treatment-Resistant Mental Health Conditions
As of July 1, psilocybin and MDMA (and related substances to both) can now be prescribed by authorized psychiatrists in Australia, which has become the
Psyched: Australia Legalizes Psychedelics Therapy, BC's Decrim, State Bills, Millions For Trials & Clinics
Australian Health Authority To Allow Psilocybin And MDMA-Assisted Therapy For Depression, PTSD Beginning on July 1, 2023, medicines containing psilocybin and MDMA can be prescribed by specifically authorized psychiatrists to treat certain mental health conditions, such as post-traumatic stress disorder and psilocybin for treatment-resistant depression.
Psychedelics And Treatment-Resistant Depression: Companies Weigh In On The Important Issue
(Part three of a four-part series) Have a look at previous stories:
Psychedelic-Assisted Therapies: Upcoming Moves In Montana, Colorado And Ontario
While psychedelics are still listed as Schedule I substances making them illegal under federal law, companies across North America are preparing to address patients’ needs in the hopefu
Compass Pathways Will Lead Two Concurrent Phase 3 Trials On Psilocybin-Assisted Therapy For Depression
Psychedelics biotech company Compass Pathways (NASDAQ: CMPS) announced it will conduct two separate Phase 3 clinical trials to study psilocybin-assisted therapy on Treatment-Resistant Depression (TRD), 
Oregon Psilocybin Services Act: State Vs. Local Decisions, The Ultimate 'Opt-Out' Choice
Oregon's elected councilors in Philomath joined the debate on whether to offer their voters to “opt out” of Measure 109, the